Literature DB >> 25833047

Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral Therapy.

G Matusali1, N Dereuddre-Bosquet2, A Le Tortorec1, M Moreau1, A-P Satie1, D Mahé1, P Roumaud1, O Bourry1, N Sylla2, S Bernard-Stoecklin2, A Pruvost3, R Le Grand2, N Dejucq-Rainsford4.   

Abstract

UNLABELLED: A number of men receiving prolonged suppressive highly active antiretroviral therapy (HAART) still shed human immunodeficiency virus (HIV) in semen. To investigate whether this seminal shedding may be due to poor drug penetration and/or viral production by long-lived cells within male genital tissues, we analyzed semen and reproductive tissues from macaques chronically infected with simian immunodeficiency virus mac251 (SIVmac251) who were treated for 4 months with HAART, which was intensified over the last 7 weeks with an integrase inhibitor. We showed that a subset of treated animals continued shedding SIV in semen despite efficient HAART. This shedding was not associated with low antiretroviral drug concentrations in semen or in testis, epididymis, seminal vesicles, and prostate. HAART had no significant impact on SIV RNA in the urethra, whereas it drastically reduced SIV RNA levels in the prostate and vas deferens and to a lesser extent in the epididymis and seminal vesicle. The only detectable SIV RNA-positive cells within the male genital tract after HAART were urethral macrophages. SIV DNA levels in genital tissues were not decreased by HAART, suggesting the presence throughout the male genital tract of nonproductively infected cells. In conclusion, our results demonstrate that 4 months of HAART induced variable and limited control of viral infection in the male reproductive organs, particularly in the urethra, and suggest that infected long-lived cells in the male genital tract may be involved in persistent seminal shedding during HAART. These results pave the way for further investigations of male genital organ infection in long-term-treated infected individuals. IMPORTANCE: A substantial subset of men receiving prolonged HAART suppressing viral loads in the blood still harbor HIV in semen, and cases of sexual transmission have been reported. To understand the origin of this persistence, we analyzed the semen and male reproductive tissues from SIV-infected macaques treated with HAART. We demonstrated that persistent seminal shedding was not linked to poor drug penetration in semen or semen-producing prostate, seminal vesicle, epididymis, and testis. We revealed that HAART decreased SIV RNA to various extents in all male genital organs, with the exception of the urethra, in which SIV RNA(+) macrophages were observed despite HAART. Importantly, HAART did not impact SIV DNA levels in the male genital organs. These results suggest that infection of male genital organs, and particularly the urethra, could be involved in the release of virus in semen during HAART.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25833047      PMCID: PMC4442442          DOI: 10.1128/JVI.03628-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  100 in total

Review 1.  The role of sexually transmitted diseases in HIV transmission.

Authors:  Shannon R Galvin; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

2.  Lower genitourinary tract sources of seminal HIV.

Authors:  Robert W Coombs; David Lockhart; Susan O Ross; Leslie Deutsch; Joan Dragavon; Kurt Diem; Thomas M Hooton; Ann C Collier; Lawrence Corey; John N Krieger
Journal:  J Acquir Immune Defic Syndr       Date:  2006-04-01       Impact factor: 3.731

Review 3.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

4.  Cytomegalovirus DNA in semen and blood is associated with higher levels of proviral HIV DNA.

Authors:  Sara Gianella; Christy M Anderson; Milenka V Vargas; Douglas D Richman; Susan J Little; Sheldon R Morris; Davey M Smith
Journal:  J Infect Dis       Date:  2012-12-28       Impact factor: 5.226

5.  HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

Authors:  Maria J Buzón; Marta Massanella; Josep M Llibre; Anna Esteve; Viktor Dahl; Maria C Puertas; Josep M Gatell; Pere Domingo; Roger Paredes; Mark Sharkey; Sarah Palmer; Mario Stevenson; Bonaventura Clotet; Julià Blanco; Javier Martinez-Picado
Journal:  Nat Med       Date:  2010-03-14       Impact factor: 53.440

6.  Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma.

Authors:  Anne-Geneviève Marcelin; Roland Tubiana; Sidonie Lambert-Niclot; Gilles Lefebvre; Stéphanie Dominguez; Manuela Bonmarchand; Daniele Vauthier-Brouzes; Françoise Marguet; Nathalie Mousset-Simeon; Gilles Peytavin; Catherine Poirot
Journal:  AIDS       Date:  2008-08-20       Impact factor: 4.177

7.  Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study.

Authors:  Martin Markowitz; Bach-Yen Nguyen; Eduardo Gotuzzo; Fernando Mendo; Winai Ratanasuwan; Colin Kovacs; Guillermo Prada; Javier O Morales-Ramirez; Clyde S Crumpacker; Robin D Isaacs; Lucinda R Gilde; Hong Wan; Michael D Miller; Larissa A Wenning; Hedy Teppler
Journal:  J Acquir Immune Defic Syndr       Date:  2007-10-01       Impact factor: 3.731

8.  Macrophage infection via selective capture of HIV-1-infected CD4+ T cells.

Authors:  Amy E Baxter; Rebecca A Russell; Christopher J A Duncan; Michael D Moore; Christian B Willberg; Jose L Pablos; Andrés Finzi; Daniel E Kaufmann; Christina Ochsenbauer; John C Kappes; Fedde Groot; Quentin J Sattentau
Journal:  Cell Host Microbe       Date:  2014-11-20       Impact factor: 21.023

Review 9.  HIV infection of the male genital tract--consequences for sexual transmission and reproduction.

Authors:  A Le Tortorec; N Dejucq-Rainsford
Journal:  Int J Androl       Date:  2009-06-15

Review 10.  Macrophages and their relevance in Human Immunodeficiency Virus Type I infection.

Authors:  Herwig Koppensteiner; Ruth Brack-Werner; Michael Schindler
Journal:  Retrovirology       Date:  2012-10-04       Impact factor: 4.602

View more
  17 in total

1.  Mass Cytometry Reveals the Immaturity of Circulating Neutrophils during SIV Infection.

Authors:  Julien Lemaitre; Antonio Cosma; Delphine Desjardins; Olivier Lambotte; Roger Le Grand
Journal:  J Innate Immun       Date:  2019-06-21       Impact factor: 7.349

Review 2.  Antiretroviral Therapy and Alcohol Interactions: X-raying Testicular and Seminal Parameters Under the HAART Era.

Authors:  Oluwatosin O Ogedengbe; Edwin C S Naidu; Onyemaechi O Azu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-04       Impact factor: 2.441

3.  Zika virus infects human testicular tissue and germ cells.

Authors:  Giulia Matusali; Laurent Houzet; Anne-Pascale Satie; Dominique Mahé; Florence Aubry; Thérèse Couderc; Julie Frouard; Salomé Bourgeau; Karim Bensalah; Sylvain Lavoué; Guillaume Joguet; Louis Bujan; André Cabié; Gleide Avelar; Marc Lecuit; Anna Le Tortorec; Nathalie Dejucq-Rainsford
Journal:  J Clin Invest       Date:  2018-07-31       Impact factor: 14.808

4.  Splenic Damage during SIV Infection: Role of T-Cell Depletion and Macrophage Polarization and Infection.

Authors:  Dionna W Williams; Elizabeth L Engle; Erin N Shirk; Suzanne E Queen; Lucio Gama; Joseph L Mankowski; M Christine Zink; Janice E Clements
Journal:  Am J Pathol       Date:  2016-06-18       Impact factor: 4.307

5.  HIV Diversity and Genetic Compartmentalization in Blood and Testes during Suppressive Antiretroviral Therapy.

Authors:  Rachel L Miller; Rosalie Ponte; Zabrina L Brumme; Jean-Pierre Routy; Bradley R Jones; Natalie N Kinloch; Fredrick H Omondi; Mohammad-Ali Jenabian; Franck P Dupuy; Remi Fromentin; Pierre Brassard; Vikram Mehraj; Nicolas Chomont; Art F Y Poon; Jeffrey B Joy
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

6.  More than a Gender Issue: Testis as a Distinctive HIV Reservoir and Its Implication for Viral Eradication.

Authors:  Jean-Pierre Routy; Franck P Dupuy; John Lin; Stéphane Isnard
Journal:  Methods Mol Biol       Date:  2022

Review 7.  HIV Latency in Myeloid Cells: Challenges for a Cure.

Authors:  Alisha Chitrakar; Marta Sanz; Sanjay B Maggirwar; Natalia Soriano-Sarabia
Journal:  Pathogens       Date:  2022-05-24

8.  HIV-1 is undetectable in preejaculatory secretions from HIV-1-infected men on suppressive HAART.

Authors:  Joseph A Politch; Kenneth H Mayer; Deborah J Anderson
Journal:  AIDS       Date:  2016-07-31       Impact factor: 4.177

Review 9.  Tissue reservoirs of HIV.

Authors:  Joseph K Wong; Steven A Yukl
Journal:  Curr Opin HIV AIDS       Date:  2016-07       Impact factor: 4.283

10.  A New Method for Rapid Screening of End-Point PCR Products: Application to Single Genome Amplified HIV and SIV Envelope Amplicons.

Authors:  Laurent Houzet; Claire Deleage; Anne-Pascale Satie; Laetitia Merlande; Dominique Mahe; Nathalie Dejucq-Rainsford
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.